Management of heterotopic pregnancy with uterine aspiration and systemic two-dose methotrexate

Autor:	Sharon L. Achilles, Beatrice A. Chen, Kavita Vinekar
Rok vydání:	2021
Předmět:	endocrine system medicine.medical_specialty medicine.drug_class Chorionic Gonadotropin 03 medical and health sciences 0302 clinical medicine Pregnancy medicine Humans Chorionic Gonadotropin beta Subunit Human 030212 general & internal medicine Pregnancy Heterotopic reproductive and urinary physiology Systemic methotrexate Retrospective Studies Abortifacient Agents Nonsteroidal 030219 obstetrics & reproductive medicine Heterotopic pregnancy urogenital system business.industry Uterus Obstetrics and Gynecology medicine.disease Surgery Methotrexate Treatment success Reproductive Medicine Female Gonadotropin business hormones hormone substitutes and hormone antagonists medicine.drug
Zdroj:	Contraception. 104:444-446
ISSN:	0010-7824
Popis:	The expected trend in serum beta-human chorionic gonadotropin (β-hCG) following treatment of an undesired heterotopic pregnancy with uterine aspiration and systemic methotrexate is not known. Thus, monitoring for treatment success is challenging. We describe an undesired heterotopic pregnancy treated with aspiration and two-dose methotrexate and report the observed β-hCG trend.
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c5eee2a1ba005453c82d584c99048271 https://doi.org/10.1016/j.contraception.2021.06.016 Zobrazit plný text záznamu Full Text from ScienceDirect